NFKB1 and cancer: When NF-κB signalling is over-expressed, either on its own or in combination with other signalling pathways, it can induce angiogenic neo-vascularization, the epithelial-mesenchymal transition (EMT), make cancer cells more “stem-like,” resistant to chemotherapy, radiation, and endocrine disruption.